Medidata to Present at the 14th Annual B. Riley & Co. Investor Conference

(NASDAQ: MDSO), the leading global provider of cloud-based solutions for the life sciences industry, today announced that Cory Douglas, chief financial officer, will present at the 14th Annual B. Riley & Co. Investor Conference on May 22, 2013, at 8:00 a.m. PT / 11:00 a.m. ET in Santa Monica, CA.

A live audio webcast will be available on the “Investor” section of Medidata’s website at . Please visit the website at least 15 minutes prior to the event to register, download and install any necessary audio or video software to access the presentation. For those unable to participate in the live webcast, a replay will be archived on the “Investor” section of Medidata’s website at for a limited time following the conference.

is the leading global provider of cloud-based solutions that enhance the efficiency of customers’ clinical trials. Medidata’s advanced platform lowers the total cost of clinical development by optimizing clinical trials from concept to conclusion: from study and protocol design, trial planning and budgeting, site negotiation, clinical portal, trial management, randomization and trial supply management, clinical data capture and management, safety events capture, medical coding to business analytics. Our diverse life science customer base spans biopharmaceutical companies, medical device and diagnostic companies, academic and government institutions, CROs and other research organizations, and includes more than 20 of the top 25 global pharmaceutical companies as well as organizations of all sizes developing life-enhancing medical treatments and diagnostics.

Suggested Articles

While the rush to telehealth adoption may have slowed a bit from its highs early on in the pandemic, the data show consumer interest in virtual care.

Allscripts reported third-quarter 2020 revenue was $402 million, down 9% from revenue of $444 million in the third quarter of 2019. 

Telehealth giant Teladoc completed its massive $18.5 billion acquisition of Livongo, the company announced Friday.